Mundipharma International Ltd - Strategic SWOT Analysis Review

Mundipharma International Ltd - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • HighlightsMundipharma International Ltd (Mundipharma) conducts research and develops products for the treatment pain management, respiratory, cancer and inflammatory conditions. The company commercializes and launches products within Europe and rest of the world. Mundipharma offers its products through its network of subsidiaries, independent associated companies, partners and joint ventures. The company’s network includes Napp Pharmaceuticals, Norpharma and the Mundipharma independent associated companies. The company provides its services to patients, healthcare professionals and health systems worldwide. It has operations in Australia, Japan, New Zealand, Russia, Singapore, Philippines, South Africa, South Korea, Canada, China and USA. Mundipharma is headquartered in Cambridge, the UK.

    Mundipharma International Ltd Key Recent Developments

    Dec 03,2018: Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI IV by the National Medical Products Administration (NMPA)
    Nov 30,2018: Mundipharma announces Marco Cerato as Senior Vice President Business Development and Strategic Partnerships
    Nov 19,2018: Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan
    Nov 19,2018: Mundipharma announces Chief Financial Officer
    Oct 05,2018: Mundipharma announces Philippe Bastide as Head of Biosimilars

    Reasons to Buy
    • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
    • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
    • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
    • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    Note: Some sections may be missing if data is unavailable for the company.


    Section 1 - About the Company
    Mundipharma International Ltd - Key Facts
    Mundipharma International Ltd - Key Employees
    Mundipharma International Ltd - Key Employee Biographies
    Mundipharma International Ltd - Major Products and Services
    Mundipharma International Ltd - History
    Mundipharma International Ltd - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture
    Section 2 - Company Analysis
    Company Overview
    Mundipharma International Ltd - Business Description
    Mundipharma International Ltd - Corporate Strategy
    Mundipharma International Ltd - SWOT Analysis
    SWOT Analysis - Overview
    Mundipharma International Ltd - Strengths
    Mundipharma International Ltd - Weaknesses
    Mundipharma International Ltd - Opportunities
    Mundipharma International Ltd - Threats
    Mundipharma International Ltd - Key Competitors
    Section 3 - Company’s Lifesciences Financial Deals and Alliances
    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Mundipharma International Ltd, Recent Deals Summary
    Section 4 - Company’s Recent Developments
    Dec 03, 2018: Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI IV by the National Medical Products Administration (NMPA)
    Nov 30, 2018: Mundipharma announces Marco Cerato as Senior Vice President Business Development and Strategic Partnerships
    Nov 19, 2018: Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan
    Nov 19, 2018: Mundipharma announces Chief Financial Officer
    Oct 05, 2018: Mundipharma announces Philippe Bastide as Head of Biosimilars
    Section 5 - Appendix
    Methodology
    About GlobalData
    Contact Us
    Disclaimer
    List of Tables
    Mundipharma International Ltd, Key Facts
    Mundipharma International Ltd, Key Employees
    Mundipharma International Ltd, Key Employee Biographies
    Mundipharma International Ltd, Major Products and Services
    Mundipharma International Ltd, History
    Mundipharma International Ltd, Subsidiaries
    Mundipharma International Ltd, Joint Venture
    Mundipharma International Ltd, Key Competitors
    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Mundipharma International Ltd, Recent Deals Summary
    List of Figures
    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Mundipharma International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook